An Important Factor—Impact
References
- De Jesús, V.R.; Mei, J.V.; Cordovado, S.K.; Cuthbert, C.D. The newborn screening quality assurance program at the centers for disease control and prevention: Thirty-five year experience assuring newborn screening laboratory quality. Int. J. Neonatal Screen. 2015, 1, 13–26. [Google Scholar] [CrossRef] [PubMed]
- Schielen, P.C.J.I.; Kemper, E.A.; Gelb, M.H. Newborn screening for lysosomal storage diseases: A concise review of the literature on screening methods, therapeutic possibilities and regional programs. Int. J. Neonatal Screen. 2017, 3, 6. [Google Scholar] [CrossRef] [PubMed]
- Dowsett, L.; Lulis, L.; Ficicioglu, C.; Cuddapah, S. Utility of Genetic Testing for Confirmation of Abnormal Newborn Screening in Disorders of Long-Chain Fatty Acids: A Missed Case of Carnitine Palmitoyltransferase 1A (CPT1A) Deficiency. Int. J. Neonatal Screen. 2017, 3, 10. [Google Scholar] [CrossRef] [PubMed]
© 2017 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fingerhut, R. An Important Factor—Impact. Int. J. Neonatal Screen. 2017, 3, 26. https://doi.org/10.3390/ijns3040026
Fingerhut R. An Important Factor—Impact. International Journal of Neonatal Screening. 2017; 3(4):26. https://doi.org/10.3390/ijns3040026
Chicago/Turabian StyleFingerhut, Ralph. 2017. "An Important Factor—Impact" International Journal of Neonatal Screening 3, no. 4: 26. https://doi.org/10.3390/ijns3040026
APA StyleFingerhut, R. (2017). An Important Factor—Impact. International Journal of Neonatal Screening, 3(4), 26. https://doi.org/10.3390/ijns3040026